Get started
Author

Caixia Li

Observed names: C X Li, Cai-Xia Li, Cai-xia Li, Caixia LI, Li Caixia
Observed institutions: Tongji University, Tianjin University of Traditional Chinese Medicine, Sun Yat-sen University, Guangdong Medical College, Guangdong Pharmaceutical University, Kunming Medical University, Soochow University, First Affiliated Hospital of Guangdong Pharmaceutical University, Tianjin Fourth Central Hospital, First Affiliated Hospital of Kunming Medical University, Southwest Hospital, Shanghai Tenth People's Hospital, Tianjin Fourth Hospital, First Affiliated Hospital of Soochow University, Qilu Hospital of Shandong University, Suzhou University
ORCID: 0000-0002-5480-3023
Observed ORCIDs: 0000-0002-5480-3023, 0000-0002-6306-6141
OpenAlex ID: A5100412339
Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden
2019 · Changju Qu, Nana Ping, et al. · Journal of Immunotherapy · 97
Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1α activation
2008 · Xubu Wang, Caixia Li, et al. · Biochemical and Biophysical Research Communications · 88
Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma
2022 · Wei Sang, Xiangmin Wang, et al. · Frontiers in Immunology · 62
PDF
Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study
2023 · Cheng-Peng Gui, Yu-Hang Chen, et al. · The Lancet Digital Health · 47
PDF
Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells
2022 · Jingwen Tan, Yujie Jia, et al. · Journal of Hematology & Oncology · 41
PDF
A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
2021 · Ying Zhang, Jiaqi Li, et al. · Frontiers in Oncology · 38
PDF
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?
2023 · Sining Liu, Xinyue Zhang, et al. · Blood Cancer Journal · 36
PDF
Correlation of LOX‑5 and COX‑2 expression with inflammatory pathology and clinical features of adenomyosis
2018 · Caixia Li, Rong Chen, et al. · Molecular Medicine Reports · 26
PDF
TGF-β1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4
2015 · Huiling Wang, Caixia Li, et al. · PLoS ONE · 26
PDF
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma
2024 · Kang-Bo Huang, Cheng-Peng Gui, et al. · Nature Communications · 22
PDF
Association of MEGSIN 2093C–2180T haplotype at the 3′ untranslated region with disease severity and progression of IgA nephropathy
2006 · Yunfeng Xia, Youji Li, et al. · Nephrology Dialysis Transplantation · 18
Case Report: Reversible Neurotoxicity and a Clinical Response Induced by BCMA-Directed Chimeric Antigen Receptor T Cells Against Multiple Myeloma With Central Nervous System Involvement
2021 · Ying Zhang, Changfeng Zhang, et al. · Frontiers in Immunology · 12
PDF
Serum CNPY2 isoform 2 represents a novel biomarker for early detection of colorectal cancer
2018 · Jianhong Peng, Qingjian Ou, et al. · Aging · 12
Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer
2023 · Jinye Ding, Yaoqi Sun, et al. · International Journal of General Medicine · 11
PDF
Efficacy and safety of raltitrexed-based transarterial chemoembolization for colorectal cancer liver metastases
2018 · Guoliang Shao, Ruibao Liu, et al. · Anti-Cancer Drugs · 10
Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients
2021 · Sining Liu, Xinyue Zhang, et al. · Blood · 8
Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy
2021 · Guang Lu, Zhiwen Lu, et al. · Computational and Mathematical Methods in Medicine · 6
PDF
The Effects and Mechanism of Scutellaria baicalensis Georgi Stems and Leaves Flavonoids on Myelin Sheath Degeneration Induced by Composite Aβ in Rats
2023 · Xu Congcong, Ye Yuanyuan, et al. · CNS & Neurological Disorders - Drug Targets · 5
Chimeric Antigen Receptor T Cell Targeting to CD19 and CD22 Combined with Anti-PD-1 Antibody Induce High Response in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
2021 · Ying Zhang, Jiaqi Li, et al. · Blood · 4
Laparoscopic regional radical hysterectomy showed promising clinical outcomes in early-stage cervical cancer
2020 · Zhongping Cheng, Weihong Yang, et al. · Gynecology and Minimally Invasive Therapy · 4
Relative Depletion of Soluble Interleukin 6 Receptors Abolished the Development of Cytokine Release Syndrome after CART19/22 and Lenalidomide Treatment for Lymphoma
2019 · Caixia Li, Changfeng Zhang, et al. · Blood · 4
Haploidentical hematopoietic stem cell transplantation with myeloablative conditioning regimen could serve as an optional salvage therapy for younger patients with refractory or relapsed aggressive non-Hodgkin lymphoma
2017 · Xiaofang Xiao, Haiwen Huang, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4
Investigation of the drug–drug interaction and incompatibility mechanism between Aconitum carmichaelii Debx and Pinellia ternata (Thunb.) Breit
2024 · Minglei Ge, Huizi Ouyang, et al. · Journal of Ethnopharmacology · 3
shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia
2019 · Liqing Kang, Xiaowen Tang, et al. · Blood · 3
[Correlation of Serum Concentration of Nilotinib with Clinical Efficacy in Patients with Chronic Myeloid Leukemia].
2018 · Tong Wang, Cai-Xia Li, et al. · PubMed · 2
Works count: 46
Citation count: 594
H-index: 12
I10-index: 15
Year
Topic
Type